Related Experiment Video
Updated: Dec 30, 2025

Isolation and Cultivation of Mandibular Bone Marrow Mesenchymal Stem Cells in Rats
Published on: August 25, 2020
Effects of icariin on osteogenic differentiation of bone marrow stromal cells in beagle canine
Guojun Miao1, Yingdi Zhang2, Yiwen Zhang1
1Shanghai Engineering Research Center of Tooth Restoration and Regeneration, School and Hospital of Stomatology, Tongji University Shanghai, P. R. China.
Icariin (ICA), as the main active component in perennial herb Epimedium, displays a wide range of pharmacological and biological effects, including enhanced sexual function, immune regulation, anti-inflammatory, and anti-osteoporosis. In this study, the effect of ICA on osteogenic differentiation of bone marrow derived stromal cells (BMSCs) from a Beagle dog was assessed. BMSCs were Isolated from the canine bone marrow, cultured and identified by applying morphology and multi-lineage differentiation assays. Cell counting kit-8 (CCK-8) assay showed that ICA significantly promoted BMSC proliferation in a dose-dependent manner. Alkaline phosphatase (ALP) activity assay showed that ICA can increase ALP activity in a dose-dependent manner. Furthermore, RT-PCR and Western-blot indicated that ICA upregulated osteogenic-related genes and proteins. Alizarin red staining demonstrated the induced calcium deposition in BMSCs treated with 10-6 mol/L ICA for 21 days. Overall, these findings clearly indicate that ICA is able to promote the osteogenic differentiation of BMSCs in beagle dogs. The optimal ICA concentration of 10-6 mol/L may be appliable in bone tissue engineering.
Icariin (ICA), as the main active component in perennial herb Epimedium, displays a wide range of pharmacological and biological effects, including enhanced sexual function, immune regulation, anti-inflammatory, and anti-osteoporosis. In this study, the effect of ICA on osteogenic differentiation of bone marrow derived stromal cells (BMSCs) from a Beagle dog was assessed. BMSCs were Isolated from the canine bone marrow, cultured and identified by applying morphology and multi-lineage differentiation assays. Cell counting kit-8 (CCK-8) assay showed that ICA significantly promoted BMSC proliferation in a dose-dependent manner. Alkaline phosphatase (ALP) activity assay showed that ICA can increase ALP activity in a dose-dependent manner. Furthermore, RT-PCR and Western-blot indicated that ICA upregulated osteogenic-related genes and proteins. Alizarin red staining demonstrated the induced calcium deposition in BMSCs treated with 10-6 mol/L ICA for 21 days. Overall, these findings clearly indicate that ICA is able to promote the osteogenic differentiation of BMSCs in beagle dogs. The optimal ICA concentration of 10-6 mol/L may be appliable in bone tissue engineering.
More Related Videos
10:32Author Spotlight: Simple Establishment of a Vascularized Osteogenic Bone Marrow Niche Using Pre-Cast Poly(Ethylene Glycol) (PEG) Hydrogels in an Imaging Microplate
Published on: May 19, 2023
11:41Derivation and Differentiation of Canine Ovarian Mesenchymal Stem Cells
Published on: December 16, 2018